{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:39:03Z","timestamp":1774265943024,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T00:00:00Z","timestamp":1411257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00296-014-3131-y","type":"journal-article","created":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T14:52:20Z","timestamp":1411224740000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"35","author":[{"given":"Serena","family":"Pastore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Stocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Moressa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Zandon\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Favretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Malus\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Decorti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,21]]},"reference":[{"issue":"9563","key":"3131_CR1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369(9563):767\u2013778","journal-title":"Lancet"},{"issue":"16","key":"3131_CR2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"EH Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA\u2013USSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children\u2019s Study Group. N Engl J Med 326(16):1043\u20131049","journal-title":"N Engl J Med"},{"issue":"4","key":"3131_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/clpt.2011.293","volume":"91","author":"ML Becker","year":"2011","unstructured":"Becker ML (2011) Optimization of pediatric rheumatology therapeutics. Clin Pharmacol Ther 91(4):597\u2013606","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"3131_CR4","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","volume":"50","author":"N Ruperto","year":"2004","unstructured":"Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F et al (2004) A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 50(7):2191\u20132201","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3131_CR5","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","volume":"64","author":"CA Wallace","year":"2012","unstructured":"Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O\u2019Neil KM, Zeft AS et al (2012) Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum 64(6):2012\u20132021","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3131_CR6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/FPC.0b013e328343dd93","volume":"21","author":"TS Mikkelsen","year":"2011","unstructured":"Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G et al (2011) PharmGKB summary: methotrexate pathway. Pharmacogenet Genomics 21(10):679\u2013686","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"3131_CR7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood.V84.2.564.564","volume":"84","author":"JC Barredo","year":"1994","unstructured":"Barredo JC, Synold TW, Laver J, Relling MV, Pui CH, Priest DG et al (1994) Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood 84(2):564\u2013569","journal-title":"Blood"},{"issue":"8","key":"3131_CR8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2010.146191","volume":"70","author":"A Hinks","year":"2011","unstructured":"Hinks A, Moncrieffe H, Martin P, Ursu S, Lal S, Kassoumeri L et al (2011) Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Ann Rheum Dis 70(8):1395\u20131400","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3131_CR9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/FPC.0b013e32833315d1","volume":"19","author":"T Dervieux","year":"2009","unstructured":"Dervieux T, Wessels JA, van der Straaten T, Penrod N, Moore JH, Guchelaar HJ et al (2009) Gene-gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis. Pharmacogenet Genomics 19(12):935\u2013944","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"3131_CR10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3899\/jrheum.111593","volume":"39","author":"MC Rotte de","year":"2012","unstructured":"de Rotte MC, Bulatovic M, Heijstek MW, Jansen G, Heil SG, van Schaik RH et al (2012) ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis. J Rheumatol 39(10):2032\u20132040","journal-title":"J Rheumatol"},{"issue":"2","key":"3131_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.2010.03814.x","volume":"71","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, Naruto T, Hara T, Kikuchi M, Hara R, Miyamae T et al (2011) Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Br J Clin Pharmacol 71(2):237\u2013243","journal-title":"Br J Clin Pharmacol"},{"key":"3131_CR12","doi-asserted-by":"crossref","unstructured":"Cobb J, Cule E, Moncrieffe H, Hinks A, Ursu S, Patrick F et al (2014) Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases. Pharmacogenomics J\u00a014(4):356\u2013364","DOI":"10.1038\/tpj.2014.3"},{"issue":"3","key":"3131_CR13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11926-013-0406-3","volume":"16","author":"CL Duurland","year":"2014","unstructured":"Duurland CL, Wedderburn LR (2014) Current developments in the use of biomarkers for juvenile idiopathic arthritis. Curr Rheumatol Rep 16(3):406","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"3131_CR14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40(7):1202\u20131209","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3131_CR15","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E (2004) Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 31(11):2290\u20132294","journal-title":"J Rheumatol"},{"issue":"5","key":"3131_CR16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658\u2013666","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3131_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/tpj.2012.7","volume":"13","author":"SA Owen","year":"2012","unstructured":"Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W (2012) Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. Pharmacogenomics J 13(3):227\u2013234","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"3131_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e32834d3e0b","volume":"22","author":"T Dervieux","year":"2011","unstructured":"Dervieux T, Wessels JA, Kremer JM, Padyukov L, Seddighzadeh M, Saevarsdottir S et al (2011) Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis. Pharmacogenet Genomics 22(1):1\u20139","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"3131_CR19","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/art.20460","volume":"50","author":"T Dervieux","year":"2004","unstructured":"Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M et al (2004) Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum 50(9):2766\u20132774","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3131_CR20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1373\/clinchem.2005.059501","volume":"52","author":"M Shipkova","year":"2006","unstructured":"Shipkova M, Lorenz K, Oellerich M, Wieland E, von Ahsen N (2006) Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype\u2013phenotype in a Caucasian population. Clin Chem 52(2):240\u2013247","journal-title":"Clin Chem"},{"issue":"4","key":"3131_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","volume":"20","author":"JB Haldane","year":"1956","unstructured":"Haldane JB (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20(4):309\u2013311","journal-title":"Ann Hum Genet"},{"issue":"8","key":"3131_CR22","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","volume":"43","author":"P Woo","year":"2000","unstructured":"Woo P, Southwood TR, Prieur AM, Dore CJ, Grainger J, David J et al (2000) Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 43(8):1849\u20131857","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3131_CR23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/acr.21697","volume":"64","author":"A Klein","year":"2012","unstructured":"Klein A, Kaul I, Foeldvari I, Ganser G, Urban A, Horneff G (2012) Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry. Arthritis Care Res 64(9):1349\u20131356","journal-title":"Arthritis Care Res"},{"key":"3131_CR24","doi-asserted-by":"crossref","unstructured":"Bulatovic Calasan M, den Boer E, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R et al (2013) Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-203723","DOI":"10.1136\/annrheumdis-2013-203723"},{"issue":"8","key":"3131_CR25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/ard.2004.033399","volume":"64","author":"T Dervieux","year":"2005","unstructured":"Dervieux T, Furst D, Lein DO, Capps R, Smith K, Caldwell J et al (2005) Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study. Ann Rheum Dis 64(8):1180\u20131185","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3131_CR26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj2360193","volume":"236","author":"JE Baggott","year":"1986","unstructured":"Baggott JE, Vaughn WH, Hudson BB (1986) Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5\u2032-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J 236(1):193\u2013200","journal-title":"Biochem J"},{"issue":"11","key":"3131_CR27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00008571-200411000-00004","volume":"14","author":"T Dervieux","year":"2004","unstructured":"Dervieux T, Kremer J, Lein DO, Capps R, Barham R, Meyer G et al (2004) Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis. Pharmacogenetics 14(11):733\u2013739","journal-title":"Pharmacogenetics"},{"issue":"4","key":"3131_CR28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/art.21726","volume":"54","author":"JA Wessels","year":"2006","unstructured":"Wessels JA, de Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YP, Allaart CF et al (2006) Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum 54(4):1087\u20131095","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3131_CR29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.tpj.6500438","volume":"7","author":"M Drozdzik","year":"2007","unstructured":"Drozdzik M, Rudas T, Pawlik A, Gornik W, Kurzawski M, Herczynska M (2007) Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis. Pharmacogenomics J 7(6):404\u2013407","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"3131_CR30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/rheumatology\/ken513","volume":"48","author":"YC Lee","year":"2009","unstructured":"Lee YC, Cui J, Costenbader KH, Shadick NA, Weinblatt ME, Karlson EW (2009) Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Rheumatology (Oxf, Engl) 48(6):613\u2013617","journal-title":"Rheumatology (Oxf, Engl)"},{"issue":"9","key":"3131_CR31","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/art.22032","volume":"54","author":"JA Wessels","year":"2006","unstructured":"Wessels JA, Kooloos WM, De Jonge R, De Vries-Bouwstra JK, Allaart CF, Linssen A et al (2006) Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 54(9):2830\u20132839","journal-title":"Arthritis Rheum"},{"issue":"4\u20135","key":"3131_CR32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","volume":"111","author":"S Sumi","year":"2002","unstructured":"Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC et al (2002) Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet 111(4\u20135):360\u2013367","journal-title":"Hum Genet"},{"issue":"21","key":"3131_CR33","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1093\/hmg\/dds302","volume":"21","author":"G Stocco","year":"2012","unstructured":"Stocco G, Yang W, Crews KR, Thierfelder WE, Decorti G, Londero M et al (2012) PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet 21(21):4793\u20134804","journal-title":"Hum Mol Genet"},{"issue":"11","key":"3131_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FPC.0b013e32833f2cd0","volume":"20","author":"H Moncrieffe","year":"2010","unstructured":"Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A, Hubank M et al (2010) Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenet Genomics 20(11):665\u2013676","journal-title":"Pharmacogenet Genomics"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3131-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3131-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T18:48:37Z","timestamp":1598294917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3131-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,21]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["3131"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3131-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,21]]}}}